I.V-Globulin SN inj.

GC Biopharma is one of the top-tier biopharmaceutical companies in South Korea with over 55 years of history and advanced technology. GC Biopharma provides premium Fill & Finish service to clinical and commercial customers for vaccines, recombinant and biosimilar pharmaceutical products. We have state-of-t...

"World’s 1st Antibiotic-free varicella vaccine" • WHO PQ vaccine  • Improved stability with automatic and aseptic process • Over the past 28 years, + 28 M doses provided • Exported more than 30 countires
• Generic name: Varicella Vaccine • Indication: For prophylaxis against varicella • Pr...

"Top 5 global flu vaccine manufacturer" • WHO PQ vaccine • Largest flu vaccine supplier to PAHO & Unicef
• + 30 M doses supplied worldwide • Generic name: Seasonal Influenza vaccine • Indication: For prophylaxis against influenza • Presentation: 0.5 mL(PFS) 0.25 mL(PFS) 0.5 mL (vial)...

"U.S Approval in 2023Succeful lunching in 2024"
• Less contaminants. More purity • Produced with cation exchange(CEX) chromatography, which results in extra-purified IVIG • Generic name: Human Normal Immunoglobulin for Intravenous Administration, 10%

"World's 1st ERT for Neuronopathic MPS II"
• Direct delivery to the ventricle • Long dosing interval (once a month) • Reduces GAG concentration in the CSF • Generic name: Idursulfase-beta • Indication: Neuronopathic Mucopolysaccharidosis type II (Hunter syndrome) as an enzyme replacement therapy...

"New opportunity for MPS II (Hunter syndrome), ERT" • World's 2nd ERT for MPS II • Serum-Free production process • High Proportion of Active-Form Enzymes • Generic name: Idursulfase-beta • Indication: Mucopolysaccharidosis type II (Hunter syndrome) as an enzyme replacement therapy(ERT) • Presentatio...

“Your CMO partner of choice, providing a seamless manufacturing experience tailored to each client” 
• 50+ Years Track Record • FDA, ANVISA, WHO PQ certification • Clinical & Commercial Aseptic Filling  • Isolator Filling Line (2R, 3R, 6R, 10R, 20R, 30R)  • Fully Automated Visual...

GC Biopharma is a global bio-tech leader that saves and improves lives, offers a broad range of vaccines, plasma derivatives, therapies for rare diseases, and medicines for chronic diseases

▪Solvent/Detergent treated and Nanofiltered ▪For intravenous use only ▪Plasma from healthy donors  

 ✔ Alyglo : Human Intravenous immunoglobulin 10%
 - U.S. Approval in 2023
 - Successfully launching in 2024

 ✔ I.V.-Globulin SN inj. : Human intravenous Immunoglobulin 5%, 10%
 - A dominant leader of Korea since 1970
 - 611 mil. liters of IVIG distributed worldwide 

▪A 20% solution of human albumin prepared with a cold ethanol fractionation method from plasma from healthy donors

▪High concentrate of human anti-haemophilic factor VIII prepared from pooled plasma of healthy donors

▪Live attenuated varicella vaccine
- WHO-prequalified
- World's 1st Antibiotic-free varicella vaccine

▪Seasonal influenza vaccine
- WHO-prequalified
- Largest flu vaccine supplier to PAHO & UNICEF

▪World's 2nd ERT for MPS II

▪World's 1st ERT for Neuronopathic MPS II

▪Natural Plant-Based Medicine for the Alleviation of Menopausal Symptoms
▪Red Clover 70% Ethanol Dried Extract Microgranules